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Oxidative stressated that bovine serum amine-oxidase (BSAO) and SPM (SPM) addition to cancer
cells induces cell growth inhibition and over-run the multi-drug resistance (MDR) phenotype through the
oxidative stress caused by polyamine metabolites. In this study, it is reported that BSAO/SPM enzymatic
system antagonizes the survival pathway induced by either docetaxel (DTX) or interferon alpha (IFNα) in
human epidermoid cancer KB cells. The combination of BSAO/SPM with either DTX or IFNα had a synergistic
effect on cell growth inhibition through apoptosis in both human epidermoid KB and breast cancer MCF-7
cell lines. The effects of the BSAO/SPM-DTX combination on apoptosis were caspase 3 and 9-dependent and
were paralleled by the enhancement of intracellular O2−, nitric oxide levels and of lipo-oxidation. The
scavenger moiety N-acetyl-cysteine antagonized the effects on apoptosis and cell growth inhibition induced
by the combination suggesting a role of the oxidative products of SPM. These effects occurred together with a
decrease of the physiological scavenger MnSOD and an increase of both p38 kinase activity and DNA damage.
The results suggest that DTX and IFNα could sensitize tumour cells to the oxidative stress and apoptosis
induced by BSAO/SPM through the induction of a survival ras-dependent pathway and the consequent
elevation of the intracellular polyamine pool. These data allow the design of new therapeutic strategy based
on the use of this combination in human neoplasms.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionPolyamines can induce apoptosis, necrosis, inhibition of cell
proliferation and inhibition of DNA and protein synthesis through
the generation of intracellular oxidative stress. A way to achieve these
effects is the addition of bovine serum amine oxidase (BSAO), a
copper-enzyme (EC 1.4.3.6.), to polyamines. BSAO is a glycoprotein of
170 kDaMW,which oxidatively deaminates the primary amino groups
of SPM and spermidine. The reaction involves oxygen and water as
substrates and leads to the formation of H2O2, aldehydes and
ammonia. In the case of SPM, the monoaldehyde, the unstable
dialdehyde or a further breakdown product, likely to be acrolein, are
formed. In the enzymatic reaction catalyzed by BSAO only H2O2 and
aldehyde(s) are responsible for cell killing demonstrating a potent
anti-tumour activity. Moreover, SPM and BSAO addition to tumour
cells is able to antagonize the multi-drug resistant phenotype [1]. Inx: +00390815665863.
.caraglia@alice.it (M. Caraglia).
l rights reserved.fact, the enzymatic SPM metabolites, H2O2 and aldehyde, sensitized
both sensitive and multidrug resistant cancer cells to the exposure to
chemotherapy agents [2–4].
In this regard, drug combinations in cancer therapy could be useful
to obtain improved clinical responses as well as the ability to use
lower concentrations of the drugs thus reducing their side effects. On
the other hand, anti-cancer agents able to induce oxidative stress are
available. In this view, both docetaxel (DTX) and interferon alpha
(IFNα) increase the level of intracellular peroxy radicals and lipid
peroxidation products [5]. Based on these data, the combination of
BSAO/SPM enzymatic systemwith different anti-cancer drugs as IFNα
or DTX could be synergistic in terms of cytotoxicity and apoptosis of
human cancer cells.
DTX is an antineoplastic agent belonging to the taxoid family
that promotes the assembly of tubulin into stable microtubules
essential for mitotic and interphase cellular functions, while
simultaneously inhibiting their disassembly in the absence of GTP
[6]. IFNα is a biological agent widely used in the therapy of several
neoplasms [7–11]. IFNα is an important regulator of cancer cell
growth and differentiation, affecting cellular communication and
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gical control of tumor growth [11]. The way by which tumor cell
growth is suppressed by IFNα is not well known. However, it is
reported that IFNα induces apoptosis in human squamous cancer
[12,13], glioma [14] and virus-infected cells [15]. Therefore, it is
likely that this cytokine acts, at least in part, through the triggering
of programmed cell death [16]. In previous in vitro studies carried
out on human epithelial tumour cells, both DTX and IFNα induced
caspase 3-dependent apoptosis and an increased ras and Erk activity
suggesting the simultaneous onset of a homeostatic anti-apoptotic
pathway in either DTX or IFNα-treated cancer cells [17]. The speciﬁc
disruption of this pathway with agents raised against ras (dominant
negatives or farnesyltransferase inhibitors) enhanced apoptosis and
anti-tumour activity of both DTX and IFNα [16–18].
Based on these results, in the present paper, we have investigated if
the cytotoxicity induced in human head and neck KB and breast MCF-
7 cancer cells by DTX or IFNα could be enhanced by BSAO/SPM
enzymatic system and if this combination could antagonize the ras-
dependent survival pathway in these cells. This study was performed
in order to both detect a new mechanism of cancer cell growth
regulation and to design a new anti-tumour intervention strategy.
2. Material and methods
2.1. Materials
DMEM, BSA and FBS were purchased from Flow Laboratories
(Milan, Italy). Tissue culture plasticware was from Becton Dickinson
(Lincoln Park, NJ). Interferon alpha-2b recombinant was a gift of
Schering (Schering-Plough, New Jersey, USA). Rabbit antisera raised
against α-tubulin, pERK-1 K-23, ERK1/2 C-14 and monoclonal
antibodies (Mab) raised against anti-p38 and anti-phospho p38
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Anti-caspase-3,-8,-9, anti-Akt MAb and the relative activity evaluation
kit, were purchased by Cell Signalling (Cell Signaling Technology, MA,
USA). Anti-pan-Ras clone 10 MAb and the relative activity evaluation
kit were purchased from Calbiochem (Darmstadt, Germany). Anti-
HSP-70 C92F3A-5 and anti-HSP-90 AC88 Mab were from StressGen
Biotech. Co. (Victoria, BC, Canada) and anti-HSP-27 G3.1MAbwas from
Afﬁnity Bioreagents (Neshanic Station, NJ). Rabbit antisera raised
against PARP, pH2AX (Ser139) and MnSOD antibodies were from
Upstate Biotechnology (Upstate, Milan, Italy). The thiobarbituric acid
(TBA) and malondialdehyde (MDA) were purchased from Sigma AG
(Sigma-Aldrich srl, Milano, Italy).
2.2. Cell culture
The human oropharyngeal epidermoid carcinoma KB and breast
MCF-7 cancer cell lines, obtained from the American Type Tissue
Culture Collection, Rockville, MD, were grown in DMEM supplemen-
ted with heat inactivated 10% FBS, 20 mM HEPES, 100 U/ml penicillin,
100 μg/ml streptomycin, 1% L-glutamine and 1% sodium pyruvate. The
cells were grown in a humidiﬁed atmosphere of 95% air/5% CO2 at
37 °C.
2.3. Puriﬁcation of BSAO
Bovine blood was withdrawn at a slaughterhouse and mixed with
3.8% sodium citrate solution (an anticoagulant) and then treated
according to Turini et al. [19] to purify the enzyme amine oxidase.
Some modiﬁcations were made to the method: a) CM-Cellulose
column, equilibrated with phosphate buffer (0.01 M) at pH 5.8, to
remove haemoglobin, followed by b) an AE-Agarose column, in
phosphate buffer (0.01 M) at pH 7.2 to eliminate ceruloplasmin.
Finally, two ionic exchange chromatographies were performed using a
Q-Sepharose column, in phosphate buffer (0.025M) at pH 6.8 and a Q-Sepharose column, in phosphate buffer (0.02 M) at pH 8.0, according
to Janes et al. [20]. The enzyme was eluted highly puriﬁed with a NaCl
gradient. All puriﬁcation steps were carried out in a cold room, at 4 °C.
2.4. Drug combination studies
For the study of the synergism on growth inhibition, KB and MCF7
cells were seeded in 96-multiwell plates at the density of 5×103 cells/
well. After 24 h incubation at 37 °C the cells were treated with
different concentrations of BSAO, SPM, DTX and IFNα. Drug combina-
tion studies were based on concentration-effect curves generated as a
plot of the fraction of unaffected (surviving) cells versus drug
concentration after 48 h of treatment. Assessment of synergy was
performed quantitating the combination index (CI) derived from the
median-effect principle of Chou and Talalay using the CalcuSyn
software (Biosoft, Ferguson, MO) [21]. The isobologram method is a
graph representation of the pharmacologic interaction and is
composed by the CI/effect curves that represent the CI versus the
fraction of cells affected/killed by the drugs in combination.
Combination data points that fall on the line (CI=1) represent an
additive drug-drug interaction, whereas data points that fall below
(CIb1) or above the line (CIN1) represent synergism or antagonism,
respectively. The dose reduction index (DRI) represents the measure
of how much the dose of each drug in a synergistic combination may
be reduced at a given effect level compared with the doses of each
drug alone. Furthermore, we analyzed the speciﬁc contribution of
both DTX and IFNα on the cytotoxic effect of the combination of drugs
by calculating the potentiation factor (PF), deﬁned as the ratio of the
IC50 of either DTX or IFNα alone to the IC50 of DTX or IFNα in
combination with SB mixture as described before; a higher PF
indicates a greater cytotoxicity [22].
2.5. Western blot analysis
KB and MCF7 cells were grown for 48 h with or without IFNα or
DTX and/or SPM/BSAO solution at 37 °C. For cell extract preparation,
the cells were washed twice with ice-cold PBS, scraped and
centrifuged for 30 min at 4 °C in 1 ml of lysis buffer (1% Triton, 0.5%
sodium deoxycholate, 0.1 mM NaCl, 1 mM EDTA, pH 7.5, 10 mM
Na2HPO4, pH 7.4, 10 mM PMSF, 25 mM benzamidin, 1 mM leupeptin,
0.025 U/ml aprotinin). Equal amounts of cell proteins were separated
by SDS-PAGE, electrotransferred to nitrocellulose and reacted with the
different antibodies. Blots were then developed using enhanced
chemiluminescence detection reagents (SuperSignal West Pico,
Pierce) and exposed to X-ray ﬁlm. All ﬁlms were scanned by using
Quantity One software (BioRad laboratories, Hercules, CA).
2.6. Measurement of polyamine content
KB and MCF-7 cells were treated with DTX or IFNα for 48 h and
then harvested by scraping. Polyamines were quantiﬁed using
reverse-phase HPLC with ﬂuorimetric detection after derivatization
with o-phthalaldehyde as previously described [23].
2.7. Flow cytometric analysis of apoptosis
Annexin V-FITC (ﬂuorescein isothiocyanate) was used in conjunc-
tion with a vital dye, Propidium Iodide (PI), to distinguish apoptotic
(Annexin V-FITC positive, PI negative) from necrotic (AnnexinV-FITC
positive, PI positive) cells. Brieﬂy, cells were incubated with Annexin-
V-FITC (MedSystems Diagnostics, Vienna, Austria) and propidium
iodide (Sigma, St. Louis, MO, USA) in a binding buffer (10 mM Hepes,
pH 7.4,150mMNaCl, 5mMKCl,1mMMgCl2, 2.5mMCaCl2) for 10min
at room temperature, washed and resuspended in the same buffer.
Analysis of apoptotic cells was performed by ﬂow cytometry (FACScan,
Becton Dickinson). For each sample, 2×104 events were acquired.
Fig. 1. Effects of SPM/BSAO mixture and Docetaxel or IFNα on Ras-dependent pathway.
(A) Western blot assay for the expression of the total ras protein. (B) Afﬁnity
precipitation of ras performed with the minimal binding domain of raf-1 conjugated
with agarose microspheres for the evaluation of ras activity as described in qMaterials
and methodsq. Determination of the expression (C) and phosphorylation (D) of erk-1
and 2 evaluated after blotting with an anti-MAPK and an anti-pMAPK speciﬁc Mab,
respectively, as described in qMaterials and methodsq. (E) Expression of the house-
keeping protein α-tubulin, used as loading control. (F) Laser scanner of the bands
associated to ras activity and pErk. The intensities of the bands were expressed as %
arbitrary units. Bars, SEs. The experiments were performed at least three different times
and the results were always similar. CTR, untreated cells; DTX, 48 h 0.23 ng/ml
Docetaxel; IFNα, 48 h 200 UI/ml Interferon-alpha; SB, 48 h 3×10−3 EU/ml BSAO+
0.075 mM SPM; SB/DTX, 48 h SB+ 0.23 ng/ml Docetaxel; SB/IFNα, 48 h SB+ 200 UI/ml
Interferon-alpha.
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separate experiments.
2.8. AKT kinase assay
KB cells were treated with BSAO-SPM solution and/or DTX as
described above. At the time of processing 1 ml ice-cold Cell Lysis
Buffer (20 mM TRIS, pH7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1%
Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM β glyceropho-
sphate, 1 mM sodium orthovanadate, 1 μg/ml leupeptine, 1 mM PMSF)
was added to cells that were incubated on ice for 10 min. The cells
were collected and transferred to microcentrifuge tubes and centri-
fuged at 1200 g for 10min at 4 °C. The supernatants were collected and
precipitated with 20 μl of IgG1 anti-Akt monoclonal antibody
immobilized with agarose beads (Cell Signaling Technology, MA,
USA) by o/n incubation with gentle rocking at 4 °C. The resulting
immunoprecipitates were then incubated for 30min at 30 °Cwith 1 μg
GSK-3 fusion protein (Cell Signaling Technology) in the presence of
200 μM ATP and Kinase Buffer (25 mM TRIS, pH 7.5, 5 mM β -
glycerophosphate, 2 mM dithiotreitol, 0.1 mM sodium orthovanadate,
10 mMMgCl2). The reactionwas terminated with the addition of 20 μl
3× SDS sample buffer. The supernatants were boiled for 5 min and
electrophorased by 12% SDS-PAGE and the protein electro-transferred
on a nitrocellulose ﬁlm. Phosphorylation of GSK-3 was detected using
as probe an anti-Phospho-GSK-3α/β(Ser21/9) rabbit polyclonal anti-
body and then with a secondary anti-rabbit HRP-conjugated mono-
clonal antibody. The ﬁlm was washed with TBS 1×–0.05% Tween 20
buffer and the speciﬁc reactivity was detected by chemiluminescence
technique (Amersham) according to the manufacturers instructions
(Cell Signaling Technology, MA, USA).
2.9. Lipid peroxidation measurement
The binding of thiobarbituric acid to malondialdehyde-bis-
(dimethylacetal) 1,1,3,3-tetramethoxypropan (MDA) formed during
lipid peroxidation results in a chromogenic complex. The level of lipid
peroxide under treatment, was determined by measuring thiobarbi-
turic acid reactive substances (TBARS) according to the method of
Esterbauer and Cheeseman (20diKI). Brieﬂy, the homogenate was
obtained by lysing 1–5 106 cells with 10% ice-cold TCA. The lysis
mixture was centrifuged at 800 g for 10 min. Aliquots (1 mL) of
supernatant were added to 1 ml of 0.6% 2-thiobarbituric acid (TBA)
and heated in a boiling water bath for 10 min. Basal levels of TBARS
were measured ﬂuorimetrically (excitation at 530 nm, emission at
550 nm) while TBARS levels induced by different drugs were
measured spectrophotometrically at 532 nm. MDA was used as
standard. TBARS levels were normalized for cell protein content.
2.10. Spectrophotometric determination of NO
The determination of serum NO concentration, expressed in μM,
has been performed with an indirect method through the measure of
serum concentrations of nitrates and nitrites. For NO determination
the spectrophotometric reaction of Griess was used [24].
2.11. Determination of caspase activity
Cells were seeded and treated as described before. At the time of
caspase determination, cells were lysed. For each reaction, 50 ml of
cell lysate was added to 1 ml reaction mixture composed of reaction
buffer, DTT 10 mM and the speciﬁc substrate peptide DEVD for
caspase-3 conjugated to 7-amino-4-triﬂuoromethylcoumarin (AFC).
The mixtures were incubated for 1 h at 37 °C. The levels of free AFC
were measured using a spectroﬂuorometer with an excitation wave-
length of 400 nm and an emission wavelength range of 480–520 nm
(peak at 505 nm).2.12. Statistical analysis
All data are expressed as mean±SD. Statistical analysis was
performed by analysis of variance (ANOVA) with Neumann–Keul's
multiple comparison test or Kolmogorov–Smirnov where appropriate.
3. Results
3.1. SPM/BSAO combination with either Docetaxel or IFNα antagonizes
activation of the Ras-dependent survival pathway in human epidermoid
KB cancer cells
We have recently demonstrated that both IFNα and DTX induce an
EGF-Ras → Erk-dependent anti-apoptotic signalling in human
epidermoid cancer cells (17). Based upon these results, we have
investigated if the SPM/BSAO mixture could have synergistic effects
on cell growth inhibition in combination with either DTX or IFNα. We
have found that the single agents and the SPM/BSAO mixture did not
affect the expression of Ras (Fig. 1A). However, DTX and IFNα used
alone for 48 h induced an about 1.5–2-fold increase of the Ras
activation ratio (calculated as the ratio between the intensities of the
bands associated with ras activity and expression, respectively). SPM/
BSAO mixture induced only a slight increase of ras activity. On the
other hand, SPM/BSAO mixture completely antagonized the effect of
Table 1
Effect of DTX and IFNα on polyamine content in KB and MCF-7 cells
Polyamine content (nmol/mg of protein)
Cells Treatment Spermidine SPM
KB
Control 26.9±2.7 9.2±2.5
DTX 39.7±3.1 17.2±2.3
IFNα 41.7±3.8 19.4±2.8
MCF7
Control 22.3±1.5 9.8±0.8
DTX 41.8±2.1 18.1±1.7
IFNα 43.5±1.4 19.9±2.6
DTX, docetaxel; IFNα, interferon alpha. The differences between treated and untreated
cells were all signiﬁcant (pb0.02).
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cells (Fig. 1B and F).
Thereafter, we have evaluated the effects of two drugs alone or in
combination with SPM/BSAO mixture on the terminal enzymes of the
survival MAPK pathway, Erk-1 and Erk-2. We have found that the
drugs added alone induced a 1.5–2-fold increase of Erk-1/2 activity as
evaluated with a western blotting assay using an antibody raised
against the phosphorylated/activated isoforms of the two enzymes
(Fig. 1D and F). The combination of the agents caused an about 50%
reduction of the activity of the two enzymes (Fig. 1D and F). On the
other hand, at the same experimental conditions neither the single
agents nor the combination induced substantial changes of Erk-1/2
expression (Fig. 1C), thus suggesting a direct effect on enzyme
activation induced by the upstream regulators rather than on enzyme
expression/content.Fig. 2. SPM/BSAO mixture and Docetaxel or IFNα have a synergistic effect on human epider
effect induced by Docetaxel or IFNα in combination with SPM/BSAO mixture (SB) at 48 h o
affected/killed by Docetaxel or IFNα in combination with SPM/BSAO mixture (SB) for the dif
DTX (IC25 of SB/IC75 of DTX) (A and B) and equitoxic concentrations of SB and IFNα (at the r
combination index. Each point is the mean of at least four different replicate experiments.3.2. Effect of DTX and IFNα treatment on KB and MCF-7 cell
polyamine pools
After proving that DTX and IFNα induced an increased activity of
Ras and Erk1/2 in human epidermoid KB cancer cells, we next
evaluated whether the level of polyamine pool could be also changed
by the pharmacological treatment in these cells. Human epidermoid
oropharyngeal (KB) and breast cancer (MCF-7) cell lines treated with
DTX or IFNα showed an increase of polyamine content (Table 1). In
detail, both DTX and IFNα induced a 1.5 and 2-fold increase in
spermidine content in KB and MCF-7 cells, respectively, and an about
2-fold increases in the SPM content (Table 1). An about 45% increase of
both SPM and spermidine contents was found in both cell lines
exposed to the combination of DTX and SPM/BSAO mixture while an
about 15% increase was evident in cells treated with themixture alone
(data not shown). Similar results were also obtained on putrescine
content (data not shown).
3.3. The SPM/BSAO mixture synergize with either DTX or IFNα on KB and
MCF-7 cell growth inhibition
On the basis of the previous results, we have studied the effect of
different concentrations of SPM/BSAO mixture (SB) in combination
with either IFNα or DTX on proliferation of human epidermoid
carcinoma cell lines, KB and MCF-7. We have performed these
experiments with MTT assay and the resulting data were elaborated
with the dedicated software Calcusyn (by Chou and Talalay, see also
qMaterials and methodsq). In details, to investigate the relative
contribution of each agent to the synergism, serial dilutions from
different mixtures of the two drugs (SB plus IFNα or DTX) were tested
using equipotent doses of the two agents (50:50 cytotoxic ratio) ormoid cancer cell growth inhibition. We have evaluated the synergistic antiproliferative
n KB and MCF7 cells. CI/fractional effect curves show the CI versus the fraction of cells
ferent cell lines. Two molar ratios were used for both cell lines: higher relative doses of
atio of their IC50s) (C and D) on KB (A and C) and MCF7 cells (B and D), respectively. CI,
Combinations were highly synergistic when CIs wereb0.5.
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of CI/fractional effect curves showing the CIs versus the fraction of
cells affected/killed by IFNα or DTX in combination with SB are
illustrated in Fig. 2 for the different cell lines. The CI values, computed
at the 50:50 and 75:25 cytotoxic ratios and calculated at concentra-
tions resulting in 50% of cell kill (CI50) for both SB/DTX and SB/IFNα are
reported in Table 2.
We have found that the combination of SB/DTX was highly
synergistic when the drugs were used at higher concentrations of
DTX on both KB and MCF-7 cell lines (Fig. 2A and B, respectively) with
CI50s (the combination index calculated for 50% cell survival by
isobologram analysis) of 0.126 and 0.25 for KB and MCF-7 cells,
respectively (Table 2). On the other hand, synergistic effects were
obtained at equitoxic concentrations of IFNα and SB on both cell lines
(Fig. 2C and D) with CI50 of 0.132 for KB cells and of 0.314 for MCF-7
cells (Table 2). In our experimental conditions, the DRI50 of DTX were
equal to 9.08 in KB and 2.5 in MCF-7 cells, respectively, when DTXwas
used at ratios with higher concentrations (Table 2). Moreover, the
DRI50 of IFNα was equal to 16.06 in KB cells and of 27.05 in MCF-7
cells, when the drugs were used at equitoxic ratios (Table 2).
Moreover, values of potentiation factor (PF) reported in Table 2
demonstrated that IFNα had an important contribution to the
cytotoxic effect of the combination in KB cells. These results
demonstrate that a very strong synergism can be recorded on cell
proliferationwhen anti-cancer drugs are used in combinationwith the
SPM/BSAO enzymatic system. Effective concentrations of both DTX
and IFNα in the combinatory experiments can be reached in vivo.
3.4. Combination between SPM/BSAO mixture and DTX increases
apoptosis in epidermoid cancer cells
We have selected the combination of SPM/BSAO mixture and DTX
that were synergistic at Calcusyn elaboration and we have evaluated
the apoptotic effects of their combination on KB cells through FACS
analysis (Fig. 3A–D) and ﬂuorescence microscopy (Fig. 3G) after
double labelling with annexin V and Propidium Iodide (PI).
We have found that the treatment with SPM/BSAO mixture and
DTX alone induced apoptosis in only 11–15% of cell population
compared to untreated cells as demonstrated with FACS analysis (Fig.
3A–C, E and F). However, when the cells were treatedwith the drugs in
combination 36% of apoptosis was found (Fig. 3D–F). Analogous
results were obtained with experiments of ﬂuorescence microscopy
after PI and annexin V labelling. Double labelling showing apoptotic
cells was evident after exposure to the combination of SPM/BSAO
mixture and DTX (Fig. 3G). The addition of DEVD-fmk, which is a
caspase-3 inhibitor, to the cells treated with the different agents
completely antagonized the apoptosis suggesting caspase 3 involve-
ment in cell death caused by the combination (Fig. 3F). These data
suggest that the synergism on cell growth inhibition induced by SPM/Table 2
Combination Index (CI)a and Dose Reduction Index (DRI)b values according to the different
Cell lines 25:75 Cytotoxic ratio
SB/DTX
CI50 (±SD) DRI50 DTX (±SD) PF DTX (±SD
KB 0.126 (0.1156) 9.082 (0.86) 4.7 (0.41)
MCF-7 0.25 (0.44) 14.42 (1.33) 2 (0.156)
CIs less than 0.5 indicated strong synergism. The linear correlation coefﬁcient (r) for the ﬁttin
the data were statistically accurate. DTX, docetaxel; SB, SPM/BSAO mixture; IFNα, interfero
The Friedman nonparamentric rank test was used to analyze the impact of the different cyt
a CI values (mean+/−standard deviation from at least three separate experiments perform
Combination index (CI) values of b1, 1, and N1 indicate synergy, additivity, and antagonism
b DRI values (mean+/−standard deviation from at least three separate experiments per
obtained for IC50 (DRI50) in combination setting compared with each drug alone. 50:50 cyto
ratio, evaluation of CIs at higher relative doses of DTX [SB (IC25)/DTX (IC75)].
c PF values (mean+/−standard deviation from at least three separate experiments perform
ratio of the IC50 of IFNα or DTX to the IC50 of SB mixture.BSAO mixture and DTX could be mediated, at least in part, by the
induction of apoptosis in human epidermoid KB cancer cells. In fact,
the combination potentiated apoptosis induced by the single agents
and the synergism recorded on cell growth inhibition could be due to
the onset of apoptosis and other cell death mechanism that were not
investigated in the present manuscript.
3.5. Effects of the different combinations on caspase activation and PARP
fragmentation
In order to characterize the apoptosis induced in these epithelial
cancer cell lines we have evaluated if the different combinations
induced the activation of mediators of the execution phase of
apoptosis. We have evaluated the activation of caspase 3 with a
ﬂuorimetric assay using the synthetic substrate, DEVD-AF. The
ﬂuorescence intensity that measures the cleavage of the substrate
increased after exposure to DTX and SPM/BSAO mixture and was
potentiated in cells treated with the combination (Fig. 4A). This effect
was speciﬁcally antagonized by the addition of the caspase-3 inhibitor
DEVD-fmk (Fig. 4A). In the same experimental conditions, we have
evaluated the effects of the different combinations on the cleavage
and the consequent activation of caspase 9, 3 and 8 with western
blotting. Caspase 8 was determined using a speciﬁc antibody that
recognizes only the intact form of the enzyme.We have found that the
single treatments increased the cleavage of caspase 3 and 9 (Fig. 4B
and C, respectively) and the combination enhanced this effect (Fig. 4B
and C, respectively). On the other hand, the different treatments
caused no changes of the levels of uncleaved caspase 8 (Fig. 4D). These
effects suggest that the apoptosis induced by combination was largely
due to caspase 9 activation, as upstream caspase, and to caspase 3
stimulation, as terminal caspase. Therefore, apoptosis was likely
paralleled by the activation of a mitochondrial apoptotic pathway.
Moreover, we have evaluated the effects of the combination on PARP
cleavage that occurs in the ﬁnal stages of apoptosis, as evaluated with
a western blotting using an antibody that recognizes both PARP
fragments. We have found that single agents caused slight PARP
fragmentation that was again increased by the combination (Fig. 4E).
3.6. Effects of SPM/BSAO mixture in combination with DTX on lipid
peroxidation and NO concentration
On the basis of the well known ability of SPM and BSAO to induce
oxidative stress through production of toxic aldehydes and conse-
quent intracellular ROS elevation, we have evaluated the effects of
combination on both lipid peroxidation and nitric oxide production
(Fig. 5A and B, respectively).We have found that single agents induced
an about 2-fold increase of lipid peroxidative damage that was
increased by the concomitant treatment (Fig. 5A). The addition of
20 mM N-acetylcysteine (NAC) completely antagonized the effectcytotoxic ratios and potentiation factor (PF)c values of DTX and IFNα
50:50 Cytotoxic ratio
SB/IFNα
) CI50 (±SD) DRI50 IFNα (±SD) PF IFNα (±SD)
0.132 (0.0423) 16.064 (1.25) 28.47 (0.35)
0.314 (0.046) 27.05 (2.752) 35.3 (4.16)
g between CIs and fractional effects was always between 0.96 and 0.99, indicating that
n alpha.
otoxic ratios on the whole cell line panel, p=0.018.
ed in quadruplicates) represent the assessment of synergy induced by drug interaction.
, respectively.
formed in quadruplicates) represent the order of magnitude (fold) of dose reduction
toxic ratio, equipotent doses of the two agents [SB (IC50)/IFNα (IC50)]; 25:75 cytotoxic
ed in quadruplicates) deﬁned the speciﬁc contribute of IFNα or DTX evaluated as the
Fig. 3. Apoptotic effects of SPM/BSAOmixture and DTX combination on human epidermoid KB cells. (A–D) FACS analysis after double labelling with Annexin V and Propidium Iodide
of KB cells treated with 3×10−3 EU/ml BSAO+ 0.075 mM SPM and/or 0.23 ng/ml Docetaxel for 48 h. (A) Untreated cells; (B) 48 h 0.23 ng/ml Docetaxel; (C) 48 h 3×10−3 EU/ml BSAO+
0.075mM SPM; (D) 48 h SB+ 0.23 ng/ml Docetaxel. The experiments were performed at least three times and the results were always similar. (E) Percentage of cells for each quadrant.
Lower left (LL) are both Annexin V-FITC and PI negative; upper left (UL) are PI positive indicating necrosis; lower right (LR) are Annexin V-FITC positive indicating early apoptosis;
upper right (UR) are both Annexin V-FITC and PI positive indicating late apoptosis. CTR, Untreated cells; DTX, 48 h 0.23 ng/ml Docetaxel; SB, 48 h 3×10−3 EU/ml BSAO+ 0.075 mM
SPM; SB/DTX, 48 h SB+ 0.23 ng/ml Docetaxel. (F) Percentage of apoptotic cells after double labelling with Annexin V and Propidium Iodide of KB cells treated with 3×10−3 EU/ml BSAO
+ 0.075 mM SPM and/or 0.23 ng/ml Docetaxel for 48 h and exposed to caspase-3 inhibitor Z-DEVD-FMK. CTR, Untreated cells; DTX, 48 h 0.23 ng/ml Docetaxel; SPM, 48 h 0.075 mM
SPM; SB, 48 h 3×10−3 EU/ml BSAO+ 0.075 mM SPM; SB/DTX, 48 h SB+ 0.23 ng/ml Docetaxel. (G) KB cells ﬁxed and processed at ﬂuorescence microscopy after PI and anti-annexin V
antibody labelling as described in “Materials and methods”. The experiments were performed at least three different times and the results were always similar. Double labelled cells
(yellow) are apoptotic cells. Bars, SEs. The experiments were performed at least three different times and the results were always similar. CTR, Untreated cells; DTX, 48 h 0.23 ng/ml
Docetaxel; SPM, 4 8 h 0.075 mM SPM; SB, 4 8 h 3 × 10 − 3 EU/ml BSAO+ 0.075 mM SPM; SB/DTX, 4 8 h SB+ 0.23 ng/ml Docetaxel.
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changes in the production of intracellular NO that was about 3-fold
increased by the combination and partially antagonized by the
addition of 20 mM NAC (Fig. 5B). Flow cytometric analysis of cells
exposed to hydroethidine showed an increase of ﬂuorescence
intensity in cells exposed to the combination, as compared to theﬂuorescence of untreated cells or cells treated with the single agents
(Fig. 5C). Hydroethidine operates effectively as a probe for measure-
ment of O2− and, therefore, these data suggested that the increase of
both lipid peroxidation and NO production was likely due to the
increase of intracellular O2− recorded in cells treated with SB and DTX.
In fact, the mean ﬂuorescence intensities (MFIs) of the cells treated
Fig. 4. Modulation of caspases 3, 8 and 9 and PARP cleavage induced by SPM/BSAO
mixture and DTX combination. The cells have been cultured for 48 hwith 3×10−3 EU/ml
BSAO+ 0.075 mM SPM and/or 0.23 ng/ml DTX. The speciﬁc caspase 3 activity (A) was
determined with a ﬂuorimetric assay as described in the “Materials and methods”
section. Western blot assay for the determination of (B and C) both intact and cleaved
isoforms of caspase 3 and caspase 9 as evaluated after blotting with an anti-caspase-3
and an anti-caspase-9 speciﬁc Mab, respectively, as described in “Materials and
methods”; (D) pro caspase-8 as evaluated after blotting with an anti-caspase-8 speciﬁc
Mab that recognise only the intact form of caspase; (E) PARP fragmentation. The
experiments were performed at least three different times and the results were always
similar. CTR, Untreated cells; DTX, 48 h 0.23 ng/ml Docetaxel; SB, 48 h 3×10−3 EU/ml
BSAO+ 0.075 mM SPM; SB/DTX, 48 h SB+ 0.23 ng/ml Docetaxel; SB/DTX+Z-DEVD-FMK,
48 h SB+ 0.23 ng/ml Docetaxel exposed to caspase-3 inhibitor Z-DEVD-FMK.
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respectively, (vs. 51.4±3.7 of control cells) while MFI in cells exposed
to the combination was 198.6±15.8. In the same experimental
conditions, the addition of NAC to cells treated with SB/DTX
combination was also able to completely antagonize the apoptosis
induced by the combination (Fig. 5D). Therefore, apoptosis and
increase in intracellular oxidative stress were likely correlated.
3.7. Effects of SPM/BSAO mixture in combination with DTX on
stress-activated signal transduction pathways
On the bases of these data, we have studied the effects of the
different treatments onmolecules involved in the regulation of stress-
activated signal transduction pathways. We have ﬁrstly evaluated theeffects of the different treatments on the expression of HSP70 and 90
in KB cells by western blot assay (Fig. 6A and B, respectively). We have
found that exposure of cells to SPM/BSAOmixture and DTX alone or in
combination did not modulate the expression of these proteins
(Fig. 6A and B). On the other hand, the single agents induced an about
1.5-fold increase of p38 kinase activity that was enhanced by the
combination (an about 2-fold increase) suggesting a triggering of
stress-dependent kinase pathways in SB/DTX-treated KB cells
(Fig. 6D). These effects occurred without change in total p38
expression (Fig. 6C). Moreover, the expression levels of the scavenger
protein MnSOD were almost unchanged in KB cells treated with the
single agents but strongly decreased (almost undetectable) in KB cells
exposed to SB/DTX combination (Fig. 6E). In conditions of high
intracellular oxidation, as recorded in SB/DTX treated KB cells, was
evidenced by an increase in the phosphorylated H2AX (Fig. 6F). Taken
together, these data suggest that SB/DTX treatment generated an
increase of intracellular ROS (directly and/or through the decrease of
scavenger systems) that, in turn, activate p38 kinase or directly cause
DNA damage leading to apoptosis (Fig. 7). Moreover, the increase in
intracellular ROS can be also induced by oxidation of intracellular
polyamines by cellular polyamine oxidase (i.e. SPM oxidase) and this
latter effect cannot be excluded in our experimental model (Fig. 7).
4. Discussion
Intracellular polyamine levels are involved in the regulation of cell
proliferation in different manners depending on their concentration
and catabolism. In fact, being positively charged, SPD and SPM interact
and stabilize DNA and RNA. Electrostatic interactions through cationic
amino groups and hydrophobic interactions through methylene
bridging groups are dominant. Therefore, polyamines may act as
ligands at multiple sites on DNA, RNA, proteins, phospholipids and
nucleotide triphosphates [25]. The inhibition of the interactions
between polyamines and DNA, and/or low level of SPM have been
found to increase DNA instability, augmented mutagenesis and cell
death. On the other hand, high intracellular levels of SPM cause an
increase of its oxidative products inducing DNA damage and cell death
for either necrosis or apoptosis. Therefore, the increrase of in situ
formation of cytotoxic polyamine metabolites can be important in
inducing anti-cancer effects. This could be achieved using pharmaco-
logical agents [26,27].
Moreover, SPM catabolic degradation has been also found closely
related to DNA oxidation, apoptosis, oxidative stress and consequent
deleterious cellular effects [1,28,29]. Among these, severe changes of
themitochondrial structure, such as dilatation of the cristae, disruption
of membranes and apoptosis occurrence were observed in both wild
type and multidrug-resistant colon adenocarcinoma and melanoma
cells treated with BSAO/SPM [30,31]. Interestingly, the multi-drug
resistant colon cancer LoVo cells weremore sensitive to cytotoxic SPM
derivatives than normal counterpart and the treatment of these cells
with SPM/BSAO antagonized their MDR phenotype. These effects were
attributed to an earlier and higher mitochondrial membrane depolar-
isation, and a higher basal production of ROS [32]. The role of oxidative
stress in cytotoxicity induced by SPM is additionally demonstrated by
the radio-sensitization of a neuroblastoma cell line induced by the
ectopic expression of murine SPMmono-oxidase (mSMO) [33]. In fact,
transfected cells have increased intracellular ROS levels that sensitize
tumour cells to the DNA damage induced by ionizing agents. The
involvement of oxidative products of polyamines in the radiosensitiza-
tion of tumor cells is supported by SPM oxidase hyperactivity in
neuroblastoma cells [33]. The polyamine-dependent intracellular ROS
elevation enhances also the anti-tumour activity of some cytotoxic
drugs as demonstated by the chemosensitization of MDR cancer cells
[1,34]. Moreover, a synergistic pharmacologic interactionwas reported
between DTX and a polyamine derivative, N1,N11-DiethylnorSPM
(DENSPM), that is a SPM analogue and prototype anti-cancer drug that
Fig. 5. Oxidative stress induced by SPM/BSAO mixture in combination with Docetaxel. Variations of (A) MDA levels expressed as % of thiobarbituric acid reactive substances (TBARs)
and of (B) nitric oxide levels in KB cells after 48 h of incubation. (C) Flow cytometric analysis of KB cells exposed to hydroethidine used as a probe for measurement of O2−. (D)
Percentage of apoptotic cells after double labelling with Annexin V and Propidium Iodide of KB cells treated with SPM/BSAO mixture and/or Docetaxel and exposed to N-
acetylcysteine. Bars, SEs. The experiments were performed at least three different times and the results were always similar. CTR, Untreated cells; DTX, 48 h 0.23 ng/ml Docetaxel; SB,
48 h 3×10−3 EU/ml BSAO+ 0.075 mM SPM; SB/DTX, 48 h SB+ 0.23 ng/ml Docetaxel; SB/DTX+NAC, 48 h SB+ 0.23 ng/ml Docetaxel+ 20 mM N-acetylcysteine.
Fig. 6. Effects of SPM/BSAO mixture in combination with Docetaxel on signal
transduction pathway induced by stress. Western blot assay for (A) the expression of
the HSP90 and (B) HSP70 evaluated after blotting with speciﬁc antibodies as described
in “Materials and methods”. Determination of the expression (C) and phosphorylation
(D) of p38 kinase evaluated after blotting with anti-p38 and an anti-pp38 speciﬁc
antibodies, respectively, as described in qMaterials andmethodsq. Western blot assay for
phosphorylated MnSOD (F) and H2AX (E) evaluated after blotting with speciﬁc
antibodies as described in “Materials and methods”. (G) Expression of the house-
keeping proteinα-tubulin, used as loading control. The experiments were performed at
least three different times and the results were always similar. CTR, Untreated cells;
DTX, 48 h 0.23 ng/ml Docetaxel; SB, 48 h 3×10−3 EU/ml BSAO+ 0.075 mM SPM; SB/DTX,
48 h SB+ 0.23 ng/ml Docetaxel.
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through the generation of H2O2. The synergistic interaction was
observed in breast cancer cell lines [35], but the mechanism of such
interaction was not investigated in this report. More recently, it was
reported that DENSPM reduces both expression and activity of AKT,
mTOR, p70S6K and eIF-4E [36].Moreover, the Akt-dependent pathway
was recently correlated to development of resistance to DTX [37]. On
the other hand, growth and survival ras-Erk and Akt-dependent
pathways have a strong regulating role on polyamine metabolism.
Transfection of colon cancer cells with ras oncogene enhances
ornithine decarboxylase (ODC) translation that is under the control
of mTOR, Akt and Erk signalling and of the phosphorylative status of
eIF4E [38]. Activated Ki-ras oncogene suppresses the polyamine
catabolism through the decrease of spermidine/SPM N1-acetyltrans-
ferase (SSAT) gene transcription [39]. The latter effect occurs through
the down regulation of PPARγ induced by ras-mediated activation of
Erk [39]. The down-modulation of SSAT leads to an elevation of
intracellular polyamine levels and above all of SPM [40].
In our experimental model cytostatic concentrations of both IFNα
and DTX induced increased activity of ras and Erk, on a protective anti-
apoptotic basis [16,17], and this effect was paralleled by a signiﬁcant
increase of intracellular polyamine levels. We hypothesize that the
addition of SPMandBSAO to eitherDTXor IFNα-treated cells induced a
synergistic effect on growth inhibition and apoptosis at least through
two mechanisms: i) boosting of a strong intracellular oxidative stress
that impairs the survival response occurring in tumour cells treated
with cytotoxic agents or BSAO/SPM alone; ii) increase of the basal
levels of polyamines mediated by the ras-dependent survival pathway
caused by the cytostatic stimulus mediated by the drug. In the latter
Fig. 7. The ras-Erk-dependent survival pathways induced by DTX and IFNα sensitizes tumour cells to oxidative stress induced by BSAO/SPM. DTX and IFNα cause a survival signal
transduction pathway mediated by ras-MEK-1-Erk-1/2. The latter induces an increase of intracellular SPM levels (right part of the chart and red arrows). The addition of SPM/BSAO
mixture induces an oxidative stress mediated by the oxidative products of SPM and this effect is enhanced by the increase of intracellular polyamine pool in either DTX or IFNα-
treated cells. The formation of oxidative products is also mediated separately by the action of intracellular SPMmonooxidase (SMO) or polyamine oxidase (PAO). Finally, the oxidative
stress induces per se apoptosis or mediates a p38 kinase apoptotic pathway (left part of the chart and blue arrows). p38 kinase, in turn, antagonizes the ras-dependent survival
pathway mediated by either DTX or IFNα through the activation of MEK-1 phosphatases.
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amine oxidases (PAO and SMO) with consequent production of higher
oxidative products. In turn, oxidative stresswas due separately to both:
i) H2O2 and aldehyde radicals produced extracellularly by BSAO/SPM
interaction and to ii) intracellular oxidation of intracellular polyamines
by PAO or SMO. Oxidative stress was paralleled by the activation of the
stress-dependent p38 kinase that is also involved in the triggering of
apoptotic machinery [41]. Interestingly, superoxide anions are formed
frommolecular O2 by the action of intracellular oxidase. Subsequently,
they are primarily degraded by conversion to H2O2 by superoxide
dismutase [42]. H2O2 can be either partially converted to reactive OH.
(another ROS) or in H2O and molecular O2 by the action of catalases.
Superoxide anion inhibits MEK-1, and subsequently ERK, via a p38
kinase effect on phosphatases PP1 and/or PP2A [43]. These data
support our ﬁndings regarding the overcoming of the Erk-dependent
survival response occurring in IFNα or DTX-treated cells after SPM/
BSAO addition.
Apoptosis induced by the combination was caspase-3 and 9-
dependent and caspase-8 independent suggesting that oxidative
stress triggered a mitochondrial-dependent apoptotic pathway. It was
also reported that apoptosis occurring in B16-F10 melanoma cells
treated with BSAO/SPM mixture was dependent on caspase-3 and -9
but not on caspase-6 [44]. Mitochondrial apoptotic pathway could be
dependent upon the DNA damage induced by oxidative stress since
the combination induced a strong phosphorylation of γH2AX.
In conclusion, we describe, for the ﬁrst time, that oxidative stress
derived from SPM catabolism potentiated the anti-cancer activity of
either DTX or IFNα. This effect was likely due to the increase of
polyamine intracellular pool mediated by the hyperactivation of a
survival ras-Erk-dependent signalling. These biochemical events
caused strong anti-proliferative and apoptotic effects that were
mediated by the activation of a mitochondrial cell death pathway
possibly triggered by DNA damage induced by oxidative products.
Therefore, the combination of BSAO/SPM with cytotoxic agents (such
as DTX and IFNα) deserves consideration in the treatment of human
oropharyngeal epidermoid and breast cancer [45]. In fact, H2O2 andaldehyde(s) could be generated in situ by delivering BSAO into the
tumor mass [46, 47] incorporating the enzyme into liposomal
vescicles as previously shown with liposomal entrapping of super-
oxide dismutase [47]. Moreover, macromolecular anticancer drugs can
be delivered also in biocompatible polymers, such as polyethylene
glycol hydrogel (PEG) coated liposomes [48,49]. In this view, we are
developing new BSAO delivery systems based on the encapsulation of
the enzyme in tumour-speciﬁc nano-technological envelops.
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